Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results
-Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain (“CINP”) Phase 2b Trial – – […]
Theriva™ Biologics anuncia resultados positivos de la segunda reunión del Comité independiente para la monitorización de los datos de VIRAGE, el ensayo clínico de Fase 2b de VCN-01 de la empresa en combinación con quimioterapia para el adenocarcinoma pancreático ductal metastásico
ROCKVILLE, Maryland, March 31, 2025 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), una empresa diversificada en fase clínica que […]
Newton Golf Company to Host Fourth Quarter and Full-Year 2024 Earnings Call on March 31, 2025
CAMARILLO, Calif., March 31, 2025 (GLOBE NEWSWIRE) — via IBN – Newton Golf Company (Nasdaq: NWTG), a developer of performance-focused […]
BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today
SUNNYVALE, Calif., March 31, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the […]
VEON Announces 2025 AGM and Board Nominees
Dubai, March 31, 2025 – VEON Ltd. (Nasdaq: VEON), a global digital operator, (“VEON” or the “Company”), today announced that […]
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
More than 92% of schizophrenia patients taking TEV-‘749 in the SOLARIS survey were satisfied or very satisfied with the initiation […]
Cnova N.V.: Information regarding buy-out of minority shareholders, suspension of trading and delisting
CNOVA N.V.Information regarding buy-out of minority shareholders, suspension of trading and delisting AMSTERDAM – 31 March 2025, 18:15 CET Cnova […]
ASP Isotopes Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results Webinar
WASHINGTON, March 31, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), announced that it […]
Check Point Software Emerges as a Leader in Attack Surface Management After Acquiring Cyberint, According to Latest GigaOm Radar Report
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global […]
Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast
PITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) — Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage […]
